Is a complete DMAC research report available?

No complete published report is available for DiaMedica Therapeutics Inc. (DMAC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DiaMedica Therapeutics Inc. (DMAC)

NASDAQ: DMAC · USD

$9.80

+1.11 (+12.8%)· Recorded snapshot

Market cap	528.5M
Net income (ttm)	-37.5M
EPS (ttm)	-$0.72
Shares out	53.9M
Volume	489,320
Beta	0.91

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -37.5M
EPS (ttm): -$0.72
Market cap: 528.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001401040
Company name	DiaMedica Therapeutics Inc.
Country	United States
Country code	US
CUSIP number	25253X207
Earnings date	2026-11-11
Earnings time	amc
Employees	35
Employees change	7
Employees growth	25%
Enterprise value	$485.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2000
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	CA25253X2077
Last 10-K release date	2026-03-30
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2018-11-15
Last stock split type	Reverse
Market cap	$528.5M
Market cap category	Small-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$9.80
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	DMAC
U.S. state	Minnesota
Website	https://www.diamedica.com

Metric

Value

Amount currency

USD

CIK code

0001401040

Company name

DiaMedica Therapeutics Inc.

Country

United States

Country code

CUSIP number

25253X207

Earnings date

2026-11-11

Earnings time

amc

Employees

Employees change

Employees growth

25%

Enterprise value

$485.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2000

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

CA25253X2077

Last 10-K release date

2026-03-30

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2018-11-15

Last stock split type

Reverse

Market cap

$528.5M

Market cap category

Small-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$9.80

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

DMAC

U.S. state

Minnesota

Website

https://www.diamedica.com

Metric	Value
Earnings yield	-7.3%
FCF / EV yield	-6.62%
FCF yield	-6.07%
P/B ratio	12.22x
Price / tangible book value	13.56x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-7.3%

FCF / EV yield

-6.62%

FCF yield

-6.07%

P/B ratio

12.22x

Price / tangible book value

13.56x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.1M
ROA	-64.12%
ROA (5Y)	-29.63%
ROCE	-102.13%
ROE	-114.62%
ROE (5Y)	-48.52%
ROIC	-74.31%

Metric

Value

Profit per employee

$-1.1M

ROA

-64.12%

ROA (5Y)

-29.63%

ROCE

-102.13%

ROE

-114.62%

ROE (5Y)

-48.52%

ROIC

-74.31%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-33,000
Depreciation and amortization	$52,000
EBIT	$-39.2M
EBITDA	$-39.2M
EPS	$-0.72
FCF per share	$-0.58
Financing cash flow	$44.2M
Free cash flow	$-31.5M
Free cash flow minus SBC	$-35.7M
Income taxes	$30,000
Investing cash flow	$-11.6M
Net borrowing	$-11,000
Net cash flow	$1M
Net income	$-37.5M
Operating cash flow minus SBC	$-35.7M
Operating income	$-39.2M
Stock-based compensation	$4.1M

Metric

Value

Capital expenditures

$-33,000

Depreciation and amortization

$52,000

EBIT

$-39.2M

EBITDA

$-39.2M

EPS

$-0.72

FCF per share

$-0.58

Financing cash flow

$44.2M

Free cash flow

$-31.5M

Free cash flow minus SBC

$-35.7M

Income taxes

$30,000

Investing cash flow

$-11.6M

Net borrowing

$-11,000

Net cash flow

$1M

Net income

$-37.5M

Operating cash flow minus SBC

$-35.7M

Operating income

$-39.2M

Stock-based compensation

$4.1M

Metric	Value
Book value per share	$0.71
Debt / equity	0
Long-term assets	$686,000
Long-term liabilities	$69,000
Net cash (debt)	$43.3M
Net cash / market cap	8.33%
Net cash growth	45.63%
Net debt / equity	-1.13
Piotroski F-Score	1
Property, plant and equipment	$286,000
Shareholders' equity	$38.3M
Tangible book value	$38.3M
Tangible book value per share	$0.71
Total assets	$45M
Total cash	$43.5M
Total debt	$185,000
Total liabilities	$6.7M
WACC	9.28%

Metric

Value

Book value per share

$0.71

Debt / equity

Long-term assets

$686,000

Long-term liabilities

$69,000

Net cash (debt)

$43.3M

Net cash / market cap

8.33%

Net cash growth

45.63%

Net debt / equity

-1.13

Piotroski F-Score

Property, plant and equipment

$286,000

Shareholders' equity

$38.3M

Tangible book value

$38.3M

Tangible book value per share

$0.71

Total assets

$45M

Total cash

$43.5M

Total debt

$185,000

Total liabilities

$6.7M

WACC

9.28%

Metric	Value
Current assets	$44.3M
Current liabilities	$6.6M
Current ratio	6.72
Net working capital	$-5.7M
Quick ratio	6.63
Working capital	$37.7M

Metric

Value

Current assets

$44.3M

Current liabilities

$6.6M

Current ratio

6.72

Net working capital

$-5.7M

Quick ratio

6.63

Working capital

$37.7M

Metric	Value
Buyback yield / dilution	-22.41%
Dividend yield	0%
Shareholder yield	-22.41%

Metric

Value

Buyback yield / dilution

-22.41%

Dividend yield

Shareholder yield

-22.41%

Metric	Value
10Y price change	148.48%
10Y return CAGR	9.53%
10Y total return	148.48%
150-day SMA	$6.81
1D price change	12.77%
1M price change	23.43%
1M total return	23.43%
1W price change	12.77%
1W total return	12.77%
1Y price change	42.44%
1Y return CAGR	42.48%
1Y total return	42.44%
20-day SMA	$8.33
200-day SMA	$7.10
3M price change	45.4%
3M total return	45.4%
3Y price change	355.81%
3Y return CAGR	65.79%
3Y total return	355.81%
50-day SMA	$7.50
50-day SMA vs 200-day SMA	50over200
52-week high	$10.42
52-week high date	2025-12-10
52-week low	$5.25
52-week low date	2026-06-11
5Y price change	147.48%
5Y return CAGR	19.87%
5Y total return	147.48%
6M price change	55.06%
6M total return	55.06%
All-time high	$44.94
All-time high date	2012-08-07
All-time low	$0.81
All-time low date	2014-12-05
Average true range (ATR)	$0.54
Average volume	227.8K
Beta (1Y)	1.01
Beta (2Y)	1.6
Beta (5Y)	0.91
Change from 52-week high	-5.95%
Change from 52-week low	86.85%
Change from all-time high	-78.19%
Change from all-time low	1,103.93%
Change from open	11.24%
Day's gap	1.38%
Dollar volume	$4.8M
High price	$10.05
Low price	$8.81
Monthly RSI	68.54
Open price	$8.81
Position in 52-week range	79.84%
Premarket change	-0.81%
Premarket close	$8.69
Premarket price	$8.62
Previous close	$8.69
Price vs 150-day SMA	43.86%
Price vs 20-day SMA	17.68%
Price vs 200-day SMA	38.03%
Price vs 50-day SMA	30.67%
Relative volume	2.2
RSI	73.76
Sharpe ratio	0.83
Sharpe ratio (3Y)	1
Sharpe ratio (5Y)	0.54
Sortino ratio	1.39
Sortino ratio (3Y)	1.8
Sortino ratio (5Y)	0.93
Volume	489.3K
Weekly RSI	68.49
YTD price change	23.12%
YTD total return	23.12%

Metric

Value

10Y price change

148.48%

10Y return CAGR

9.53%

10Y total return

148.48%

150-day SMA

$6.81

1D price change

12.77%

1M price change

23.43%

1M total return

23.43%

1W price change

12.77%

1W total return

12.77%

1Y price change

42.44%

1Y return CAGR

42.48%

1Y total return

42.44%

20-day SMA

$8.33

200-day SMA

$7.10

3M price change

45.4%

3M total return

45.4%

3Y price change

355.81%

3Y return CAGR

65.79%

3Y total return

355.81%

50-day SMA

$7.50

50-day SMA vs 200-day SMA

50over200

52-week high

$10.42

52-week high date

2025-12-10

52-week low

$5.25

52-week low date

2026-06-11

5Y price change

147.48%

5Y return CAGR

19.87%

5Y total return

147.48%

6M price change

55.06%

6M total return

55.06%

All-time high

$44.94

All-time high date

2012-08-07

All-time low

$0.81

All-time low date

2014-12-05

Average true range (ATR)

$0.54

Average volume

227.8K

Beta (1Y)

1.01

Beta (2Y)

1.6

Beta (5Y)

0.91

Change from 52-week high

-5.95%

Change from 52-week low

86.85%

Change from all-time high

-78.19%

Change from all-time low

1,103.93%

Change from open

11.24%

Day's gap

1.38%

Dollar volume

$4.8M

High price

$10.05

Low price

$8.81

Monthly RSI

68.54

Open price

$8.81

Position in 52-week range

79.84%

Premarket change

-0.81%

Premarket close

$8.69

Premarket price

$8.62

Previous close

$8.69

Price vs 150-day SMA

43.86%

Price vs 20-day SMA

17.68%

Price vs 200-day SMA

38.03%

Price vs 50-day SMA

30.67%

Relative volume

2.2

RSI

73.76

Sharpe ratio

0.83

Sharpe ratio (3Y)

Sharpe ratio (5Y)

0.54

Sortino ratio

1.39

Sortino ratio (3Y)

1.8

Sortino ratio (5Y)

0.93

Volume

489.3K

Weekly RSI

68.49

YTD price change

23.12%

YTD total return

23.12%

Metric	Value
Float	25.3M
Float percentage	46.91%
Shares change (QoQ)	0.19%
Shares change (YoY)	22.41%
Shares held by insiders	46.69%
Shares held by institutions	20.56%
Shares outstanding	53.9M
Short % of float	22.06%
Short % of shares	10.35%
Short ratio	28.4 days

Metric

Value

Float

25.3M

Float percentage

46.91%

Shares change (QoQ)

0.19%

Shares change (YoY)

22.41%

Shares held by insiders

46.69%

Shares held by institutions

20.56%

Shares outstanding

53.9M

Short % of float

22.06%

Short % of shares

10.35%

Short ratio

28.4 days

DiaMedica Therapeutics Inc. (DMAC)

Price

Financial snapshot

Fair-value bridge

Latest news · DMAC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DMAC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DMAC

Frequently asked questions